Market Definition 

A syringe is a medical device used to inject fluid inside the body and withdraw fluid outside the body. A syringe consists of a needle attached to a hollow cylinder which is fitted with a sliding plunger. 

Global syringes market is estimated to reach $XX billion by 2027, growing at a CAGR of 8.8% till 2027. 

Market Dynamics 

The rising prevalence of chronic diseases is booting the wearable patch market. For instance, according to the World Health Organization, the chronic disease had risen by 57% in 2020. According to the National Health Council, chronic diseases affect around 133 million Americans, representing more than 45% of the total population in 2018. According to the European Commission, Chronic diseases together account for over 86% of deaths in the European Union. According to World Health Organization (WHO), Cardiovascular diseases (CVDs) are the leading cause of death globally. About 17.9 million people die due to CVD each year, an estimate of 31% of deaths globally. More than 75% of cardiovascular disease deaths occur in lower and middle-income countries. According to the Centers for Disease Control and Prevention (CDC), in 2020, around 34.2 million people have diabetes in the United States. Further, the growing demand for vaccination and immunization is a key driving factor of the market. Vaccination and immunization have raised the demand for syringes in the global market. The outbreak of COVID-19 has raised the demand for vaccination, which will lead to the rising demand for syringes. However, product recall of syringes might hamper the market growth. For instance, Fagron Sterile Services has voluntarily recalled two lots of Neostigmine Methylsulfate 5mL syringes to the user at the hospital and clinic level. Neostigmine Methylsulfate 5mL syringes product lots were recalled because of a customer complaint that some syringe units containing Neostigmine Methylsulfate 1mg/mL, 5mg per 5mL are incorrectly labelled as Neostigmine Methylsulfate 1mg/mL, 3mg per 3mL. Moreover, rising investment for facility expansion to develop syringes would provide lucrative opportunities for the market in coming years. 

Market Segmentation 

The global syringes market is mainly classified based on type, usage, and end-use. Type is further segmented into General Syringes, Specialized Syringes, and Smart Syringes. By usage, the market is divided into Disposable Syringes and Reusable Syringes. By end-use, the market is further divided into Hospitals and Clinics, Blood Collection Centers, and Others. 

Based on type, specialized syringes showed significant growth in 2020, attributing to rising demand for specialized syringes for vaccination and tetanus, the collaboration between companies to develop and distribute specialized syringes, and rising investment for a manufacturing facility to develop specialized syringes. For instance, Baxter International Inc. has invested $50 million for the expansion of its sterile fill/finish manufacturing facilities located in Bloomington, Ind. The facilities will be operated by Baxter’s BioPharma Solutions business, a premier contract manufacturing organization that specializes in parenteral (injectable) pharmaceuticals.  

Regional Analysis 

Based on geography, the global syringes market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided into the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa. 

North America was dominating the syringes market in 2020 owing to the increasing cases of chronic diseases, the presence of major players in this region, the collaboration between companies for the distribution of syringes in the North American market, and commercialization of prefilled syringes in the United States. For instance, Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, has introduced a new prefilled syringe capability in the US through its subsidiary, Hikma Pharmaceuticals USA Inc. The company has introduced Heparin Sodium Injection prefilled syringes that are ready-to-administer that helps hospitals, pharmacists, doctors and nurses treat patients faster, and easier and with reduced risk. 

Competitive landscape 

Key players operating in the syringes industry include B. Braun Melsungen AG, Becton, Dickinson and Company, Thomas Scientific, NIPRO Medical Corporation, Smiths Medical, SCHOTT AG, Hindustan Syringes & Medical Devices Ltd., Gerresheimer AG, Terumo Corporation, and Codan Medizinische Gerate GmbH & Co Kg. 

The strategic acquisition of the company to expand its geographic presence for syringes, commercialization of regulatory approved syringes, the agreement between companies for development and distribution of syringes, increasing awareness on specialized syringes, and rising investment for o expand and upgrade manufacturing capacity and technology for pre-fillable syringes are some of the strategies adopted by the major companies. For instance, on December 2, 2020, BD is planning to invest approximately $1.2 billion over a four-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) across six global manufacturing locations and will add a new manufacturing facility in Europe. The investment will be used for capacity expansion, manufacturing technology enhancements, new product innovations, and business continuity improvements across its existing network.     

Syringes Market Key Segments: 

By Type 

• General Syringes 
• Specialized Syringes 

• Smart Syringes 

By Usage 

• Disposable Syringes 
• Reusable Syringes 

By End-Use 

• Hospitals and Clinic 
• Blood Collection Centers 
• Others 

Key Global Syringes Industry Players 

• B. Braun Melsungen AG 

• Becton, Dickinson and Company 
• Thomas Scientific 
• NIPRO Medical Corporation 
• Smiths Medical 
• SCHOTT AG 

• Hindustan Syringes & Medical Devices Ltd. 
• Gerresheimer AG 
• Terumo Corporation 
• Codan Medizinische Gerate GmbH & Co Kg 

What Report Provides 

• Full in-depth analysis of the parent Industry 
• Important changes in market and its dynamics 
• Segmentation details of the market 
• Former, on-going, and projected market analysis in terms of volume and value 
• Assessment of niche industry developments 

• Market share analysis 
• Key strategies of major players 
• Emerging segments and regional growth potential